The company said Friday it develops medicines designed to precisely target disease pathology with an initial emphasis on the innate immune system. Odyssey said its most advanced programs include ...
Scott Bessent, Trump’s pick for Treasury Secretary, said that he would have to study the long-term future of the tool.